Blueprint Medicines Corp. (BPMC)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 667 |
% of all portfolios: | 0.003% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q2  2024 | |||||
≡ | Torray Funds | Reduce 16.36% | 3,178 | 0.05 | |
Q4  2023 | |||||
≡ | Torray Funds | Reduce 22.41% | 5,556 | 0.08 | |
Q4  2021 | |||||
≡ | Torray Funds | Reduce 27.41% | 4,368 | 0.07 | |
Q2  2021 | |||||
≡ | Stephen Mandel - Lone Pine Capital | Sell 100.00% | 2,709,138 | 0.96 | |
≡ | Viking Global Investors | Sell 100.00% | 213,050 | 0.06 | |
Q1  2021 | |||||
≡ | Viking Global Investors | Reduce 21.87% | 59,631 | 0.02 | |
Q4  2020 | |||||
≡ | Viking Global Investors | Reduce 80.94% | 1,158,086 | 0.34 | |
Q3  2020 | |||||
≡ | Viking Global Investors | Reduce 12.21% | 198,949 | 0.07 | |
Q2  2019 | |||||
≡ | Viking Global Investors | Reduce 16.34% | 107,621 | 0.04 | |
Q1  2018 | |||||
≡ | Leon Cooperman | Sell 100.00% | 75,000 | 0.21 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.